Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Treatment of refractory splenomegaly in myeloproliferative disease by splenic artery infusion.

Treatment of refractory splenomegaly in myeloproliferative disease by splenic artery infusion. Blood. 1979 May; 53(5):1014-7.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.